Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 4Active not recruiting 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1

Conditions

Neoplasms 2Stress, Psychological 1Head and Neck Neoplasms 1Alzheimer Disease 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Amyloid × Clear all
NCT05126823 2026-05-05

Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients

Universidad de Córdoba

Phase NA Active not recruiting
120 enrolled
Tumor-Agnostic

Neoplasms

NCT05997329 2025-09-08

NUTREAT

University of Oslo

Phase NA Active not recruiting
125 enrolled
Head & Neck

Head and Neck Neoplasms

NCT02939612 2025-03-20

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

Oslo University Hospital

Phase NA Active not recruiting
200 enrolled

Alzheimer Disease, Neoplasms, Stress, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡